Regulatory Affairs

Marketing Authorization Holder (MAH)

Chief Pharmacist

Any company, firm or non-profit organization, which holds a marketing authorization granted by the European Medicines Agency (EMA), is called ...

Understanding CEP, DMF, CADIFA and ASMF

Chief Pharmacist

CEP (Certificate of Suitability to the Monographs of the European Pharmacopoeia) DMF (Drug Master File) CADIFA (Certificado de Adequação de ...

Post-Approval Changes in Pharmaceutical Industry

Chief Pharmacist

Post-approval changes in pharmaceutical companies refer to any modifications made to a drug product or its manufacturing process after receiving ...

Key Aspects of SUPAC Guidelines

Chief Pharmacist

SUPAC (Scale-Up and Post-Approval Changes) is a set of guidelines issued by the U.S. Food and Drug Administration (FDA) to ...

Drug Master File (DMF)

Chief Pharmacist

A DMF is a confidential document submitted to the FDA by a pharmaceutical manufacturer, containing detailed information about the facilities, ...

Regulatory Authorities

Chief Pharmacist

Regulatory authorities enforce legal frameworks for new drug products or medical devices approval in market. For example, US FDA oversees ...

Dossier

Chief Pharmacist

It is a set of documents which contains technical information about the drug product. The information includes administrative, quality, non-clinical ...